PLSE

45.5502.57%
LT

Liane Teplitsky

Chief Operating Officer

Ms. Liane Teplitsky is Chief Operating Officer of Pulse Biosciences, Inc. from April 2026. Ms. Teplitsky joined the Pulse Biosciences, Inc. in April 2026. Ms. Teplitsky was an Independent Director of Carvolix SA (formerly known as Affluent Medical SA) from February 5, 2025 and served as its Executive Chairman of the Board and served as its Chairman of the Board since 2026 until September 30, 2026 and also serves as its Director since February 05, 2025. Ms. Teplitsky served as Chief Executive Officer of ArteDrone S.A.S. from February 2025. She is a successful seasoned senior executive in the medical device and technology industry with achievements in building, leading and growing innovative businesses that elevate the standard of patient care. With an extensive background in R&D and a passion for advancing intelligent and life-changing medical technologies, she has cultivated an expertise in leading business strategy, clinical data development and commercialization for multimillion-dollar global medical technology franchises. Additionally, she has demonstrated excellence in building and leading high functioning, highly engaged teams. She was President, Global Robotics, Technology & Data Solutions at Zimmer Biomet where she led the global growth and development of the company’s portfolio of robotics and digital health technologies. Prior to Zimmer Biomet, she spent nearly a decade in executive leadership roles at Abbott and St. Jude Medical, with a focus on cardiac diseases and diagnostics. She holds a Master of Science in Biomedical Engineering from Duke University and a Bachelor of Science in Electrical Engineering and a Bachelor of Science in Physiology from the University of Saskatchewan.

Positions